Table:
begin	end	state
1	5	non-cytoplasmic
6	32	transmembrane
33	43	cytoplasmic
44	66	transmembrane
67	93	non-cytoplasmic
94	115	transmembrane
116	135	cytoplasmic
136	159	transmembrane
160	165	non-cytoplasmic
166	190	transmembrane
191	209	cytoplasmic
210	231	transmembrane
232	237	non-cytoplasmic
238	256	transmembrane
257	267	cytoplasmic
268	290	transmembrane
291	309	non-cytoplasmic
310	341	transmembrane
342	352	cytoplasmic
353	377	transmembrane
378	392	non-cytoplasmic
393	417	transmembrane
418	426	cytoplasmic

Input:
>SM_b20297
MATLFGGWFALLIAGMPVGFTLIVAALAYMLWQGTGLNFAGQRMIAGLNSFPLLAVPFFI
LTAQLMNLSGVTERIFDFAKALVGHIRGGLGHVNIMASVLFSGMSGSAVADAAGLGQLEI
KAMRDAGYDEQFSGSITAASAIIGPLIPPSIPLVVYGVIANTSIGGLFLGGIVPGLLCAA
SLMIMVYVIAWRRNYATAQRAGFRRVWSTFWHALLPLITPFIIIGGIFAGVFSPTEAAVV
AASYALFLGVVVYREITFAKLVTVLRETVSHTAAVGLLIMGVSLFGYVIAREQVPQHVAT
FFLTYAEDPLTFLILVNLMLLALGTFIEALAILLLIVPVLVPTALQFGVDPVHFGVMVVF
NLMIGILTPPMGVALFVVSKVADIPFGVLARGILPLLIPLVVVLVLITIFPALVTFIPDQ
MLGAAR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server